SEC Info - Nymox Pharmaceutical Corp.

SEC Info℠

Home

Help

Please Sign In

Nymox Pharmaceutical Corp. – ‘6-K’ for 3/31/21

On: Friday, 5/14/21, at 3:20pm ET · For: 3/31/21 · Accession #: 1640334-21-1149 · File #: 1-12033

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/14/21  Nymox Pharmaceutical Corp.        6-K         3/31/21   42:1.4M                                   Pubco Reporting … Inc/FA

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current, Quarterly or Annual Report by a Foreign    HTML     17K 
                Issuer                                                           
 2: EX-99.1     Miscellaneous Exhibit                               HTML    152K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     19K 
 4: EX-99.3     Miscellaneous Exhibit                               HTML     19K 
11: R1          Cover                                               HTML     27K 
12: R2          Consolidated Statements of Operations (Unaudited)   HTML     61K 
13: R3          Consolidated Statements of Financial Position       HTML     65K 
14: R4          Consolidated Statements of Financial Position       HTML     15K 
                (Parenthetical)                                                  
15: R5          Consolidated Statements of Cash Flows (Unaudited)   HTML     60K 
16: R6          Consolidated Statements of Changes in Equity        HTML     35K 
                (Unaudited)                                                      
17: R7          Basis of preparation                                HTML     18K 
18: R8          Liquidity, Going Concern and Managements Response   HTML     15K 
19: R9          Share capital                                       HTML     36K 
20: R10         Earnings per share                                  HTML     19K 
21: R11         Operating lease and other commitments               HTML     29K 
22: R12         Related Party Transactions                          HTML     20K 
23: R13         Subsequent events                                   HTML     14K 
24: R14         Basis of preparation (Policies)                     HTML     20K 
25: R15         Share capital (Tables)                              HTML     33K 
26: R16         Earnings per share (Tables)                         HTML     17K 
27: R17         Operating lease and other commitments (Tables)      HTML     27K 
28: R18         Related Party Transactions (Tables)                 HTML     17K 
29: R19         Share capital (Details)                             HTML     34K 
30: R20         Share capital (Details 1)                           HTML     19K 
31: R21         Share capital (Details 2)                           HTML     19K 
32: R22         Share capital (Details Narrative)                   HTML     21K 
33: R23         Earnings per share (Details)                        HTML     19K 
34: R24         Operating lease and other commitments (Details)     HTML     17K 
35: R25         Operating lease and other commitments (Details 1)   HTML     22K 
36: R26         Operating lease and other commitments (Details      HTML     23K 
                Narrative)                                                       
37: R27         Related Party Transactions (Details)                HTML     20K 
38: R28         Related Party Transactions (Details Narrative)      HTML     21K 
39: R29         Subsequent events (Details Narrative)               HTML     25K 
41: XML         IDEA XML File -- Filing Summary                      XML     68K 
40: EXCEL       IDEA Workbook of Financial Reports                  XLSX     34K 
 5: EX-101.INS  XBRL Instance -- nymox-20210331                      XML    320K 
 8: EX-101.CAL  XBRL Calculations -- nymox-20210331_cal              XML     85K 
10: EX-101.DEF  XBRL Definitions -- nymox-20210331_def               XML    136K 
 7: EX-101.LAB  XBRL Labels -- nymox-20210331_lab                    XML    352K 
 9: EX-101.PRE  XBRL Presentations -- nymox-20210331_pre             XML    273K 
 6: EX-101.SCH  XBRL Schema -- nymox-20210331                        XSD    107K 
42: ZIP         XBRL Zipped Folder -- 0001640334-21-001149-xbrl      Zip     44K

‘6-K’ — Current, Quarterly or Annual Report by a Foreign Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the period ended March 31, 2021

Commission File Number: 001-12033

Nymox Pharmaceutical Corporation

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(l): ☐

Indicate by check mark if the registrant is submitting Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby

furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-______________

Exhibits

99.1		Quarterly Report for the Quarter ended March 31, 2021
99.2		CEO Certifications
99.3		CFO Certifications

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	NYMOX PHARMACEUTICAL CORPORATION
	(Registrant)

	By:	/s/ *Paul Averback, MD*
	Paul Averback, MD
	President and Chief Executive Officer

Date: May 14, 2021

Dates Referenced Herein and Documents Incorporated by Reference

This ‘6-K’ Filing	Date	Other Filings

Filed on:	5/14/21	UPLOAD
For Period end:	3/31/21
		List all Filings

↑Top

Filing Submission 0001640334-21-001149 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)